DKC1 and colorectal carcinoma: Given that DKC1 can drive CRC proliferation by activating the RAS/RAF/MEK/ERK signaling pathway [10], which integrates surface receptor signals into nuclear pathways, we hypothesize that TRUB1 may similarly influence CRC development and prognosis through nuclear pathways.